Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Use minoxidil for hair loss treatment; assess results after 6 months.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.